2x Blend: CJC 1295 (5 mg)/Ipamorellin (5mg): 10 mg vial

This blend combines CJC-1295, a Growth Hormone-Releasing Hormone (GHRH) analog, and Ipamorelin, a Growth Hormone Secretagogue (GHS), to synergistically stimulate the natural release of Growth Hormone (GH).

CJC-1295 (5mg)
Stimulates the pituitary gland to release GH in a pulsatile manner.

• Increases IGF-1 levels, leading to enhanced muscle growth, fat loss, and recovery.
• The DAC (Drug Affinity Complex) version extends its half-life, allowing for sustained GH release.

Ipamorelin (5mg)

• Selectively mimics Ghrelin, stimulating GH release without increasing cortisol or prolactin (unlike other GH secretagogues).
• Works synergistically with CJC-1295 to amplify GH secretion without desensitizing the pituitary.
• Has a shorter half-life (~2 hours), making it ideal for boosting natural GH pulses multiple times per day.

1. Enhanced Muscle Growth & Recovery – Increases GH and IGF-1, promoting lean muscle development and faster recovery.
2. Fat Loss & Metabolism Boost – Stimulates lipolysis (fat breakdown) and enhances metabolic rate.
3. Improved Sleep & Anti-Aging Effects – Deepens sleep quality, supports cell regeneration, skin health, and tissue repair.
4. Joint, Tendon, & Ligament Repair – Helps reduce inflammation and accelerate injury recovery.
5. No Unwanted Hormonal Side Effects – Unlike other GH secretagogues, Ipamorelin does not spike cortisol, prolactin, or ghrelin, reducing side effects like water retention or mood swings.

• Mild Water Retention – Due to GH fluctuations.
• Injection Site Reactions – Possible redness, irritation, or swelling at the injection area.
• Temporary Hunger Increase – More noticeable with Ipamorelin but usually subsides.
• Headaches & Dizziness – Rare, but possible due to fluctuations in GH levels.
• Numbness/Tingling in Extremities – Related to GH effects on nerve sensitivity and circulation.

1. Active Cancer or Tumor History – GH and IGF-1 can promote cell growth, making it unsafe for individuals with cancer risk.
2. Diabetes or Insulin Resistance – Increased IGF-1 levels can affect insulin sensitivity and glucose metabolism.
3. Pregnant or Breastfeeding Women – No sufficient safety data available.
4. Individuals with Pituitary Disorders – May not respond well or could experience hormonal imbalances.
5. Uncontrolled High Blood Pressure or Cardiovascular Issues – Growth hormone may cause fluid retention, mild increases in BP, or vascular changes.